EDAP TMS S.A. - AMERIC

EDAP Announces Second Quarter 2023 Financial Results

24 Aug 2023 05:30:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023  

10 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer

26 Jul 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP to Present at the Jefferies Healthcare Conference

24 May 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces First Quarter 2023 Financial Results

17 May 2023 05:30:00 By Nasdaq GlobeNewswire

EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023  

03 May 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)

21 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience

10 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan

06 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy

30 Mar 2023 05:30:00 By Nasdaq GlobeNewswire

EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23

21 Mar 2023 15:30:00 By Nasdaq GlobeNewswire

EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th

09 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue

14 Feb 2023 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis

31 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Record Q4 US Focal One Placements

05 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary

06 Dec 2022 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis

30 Nov 2022 15:01:00 By Nasdaq GlobeNewswire

EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference

21 Nov 2022 07:00:00 By Nasdaq GlobeNewswire

EDAP Reports Third Quarter 2022 Results

16 Nov 2022 15:35:00 By Nasdaq GlobeNewswire

EDAP TMS SA to Announce Third Quarter 2022 Financial Results on Wednesday, November 16th, 2022

02 Nov 2022 07:00:00 By Nasdaq GlobeNewswire